4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-26-000145
Director sold 4,000 shares at an average $82.66 ($330,640)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2026-07-31 | Sale 10b5-1 | −2,000 | $80.00 | $160,000 | 50,852 | I |
| FOLETTA MARK G Director | 2026-08-03 | Sale 10b5-1 | −2,000 | $85.32 | $170,640 | 48,852 | I |
| Open-market sales · 4,000 sh · avg $82.66 · $330,640 | |||||||
Loading xslF345X06/wk-form4_1785875897.xml…